Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
11°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
53.25
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
39
40
Next >
The 3 Best Pharma Stocks to Buy Now: September 2023
September 08, 2023
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.
Via
InvestorPlace
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
September 06, 2023
President Joe Biden’s Inflation Reduction Act, which allows Medicare to negotiate the price of some prescription drugs, remains the talk of the town as investors sell off shares in pharmaceutical...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
Via
Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
On Friday, Judge Thomas Rose, serving in the U.S.
Via
Benzinga
(BMY) - Analyzing Bristol-Myers Squibb's Short Interest
August 31, 2023
Via
Benzinga
Bristol-Myers Squibb Unusual Options Activity For August 21
August 21, 2023
Via
Benzinga
3 No-Brainer Dividend Stocks to Buy in September
September 02, 2023
Income investors should really like these biopharma stocks with juicy dividends.
Via
The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
3 Undervalued Healthcare Stocks In 2023
August 31, 2023
These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.
Via
Talk Markets
Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet
August 31, 2023
The Biden administration's move to lower drug prices has prompted a flurry of legal challenges.
Via
Benzinga
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Check Out What Whales Are Doing With BMY
August 17, 2023
Via
Benzinga
2 Dividend Stocks to Buy Hand Over Fist
August 16, 2023
Both of these companies offer more than consistent income.
Via
The Motley Fool
(BMY) - Analyzing Bristol-Myers Squibb's Short Interest
August 15, 2023
Via
Benzinga
Bristol Myers' Expanded Approval For Anemia Drug, Shows Superior Efficacy Over Concurrent Blood Transfusion
August 29, 2023
On Monday, the FDA approved Bristol Myers Squibb Co's (NYSE: BMY) Reblozyl (luspatercept-aamt) for anemia without previous erythropoiesis-stimulating agent use (ESA-naïve) in adult patients with very...
Via
Benzinga
Exposures
Product Safety
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
Coinbase Global, Bristol-Myers Squibb And 2 Other Stocks Insiders Are Selling
August 29, 2023
The Nasdaq 100 closed higher by over 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
2 Blue Chip Dividend Stocks That Are Top Buys in August
August 14, 2023
These two dividend-paying healthcare stocks stand out as top buys right now.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
Via
Benzinga
A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications
August 28, 2023
Some of the most frequently prescribed medications in the U.S. might soon become more affordable.
Via
Benzinga
Is Alexandria Real Estate Equities a Buy?
August 26, 2023
Great company, attractive valuation, lousy sector.
Via
The Motley Fool
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
AstraZeneca Plc (NASDAQ: AZN) announced its legal challenge against the U.S.
Via
Benzinga
GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus
August 24, 2023
Inflammatory diseases are chronic conditions that involve the abnormal activation of the body's immune system, leading to chronic inflammation in various organs and tissues. Two of these diseases that...
Via
Benzinga
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
August 23, 2023
Here are just a few top biotech stocks that may be on the cusp of major, game-changing discoveries, thanks to AI.
Via
InvestorPlace
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.
Via
InvestorPlace
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.
Via
Talk Markets
Bristol Myers' Investigational Lung Cancer Candidate Shows High Response Rates
August 16, 2023
Bristol Myers Squibb & Co (NYSE: BMY) announced updated results from a TRIDENT-1 study, demonstrating that repotrectinib — a next-generation ROS1/TRK tyrosine kinase inhibitor (TKI) — continued to show...
Via
Benzinga
UnitedHealth Group, Pioneer Natural Resources And A Credit Card Giant: CNBC's 'Final Trades'
August 14, 2023
On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management named American Express Company (NYSE: BMY) as her
Via
Benzinga
Topics
Credit Cards
Exposures
Interest Rates
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.